{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:00:36Z","timestamp":1791583236026,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T00:00:00Z","timestamp":1493510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00228-017-2257-8","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T18:38:51Z","timestamp":1493491131000},"page":"927-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-999X","authenticated-orcid":false,"given":"Emily","family":"Reeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,30]]},"reference":[{"key":"2257_CR1","unstructured":"(2016) Australian medicines handbook. In: ed. Australian medicines handbook"},{"issue":"11","key":"2257_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","volume":"17","author":"RG Cumming","year":"2003","unstructured":"Cumming RG, Le Conteur DG (2003) Benzodiazepines and risk of hip fractures in older people. CNS Drugs 17(11):825\u2013837","journal-title":"CNS Drugs"},{"issue":"12","key":"2257_CR3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M (2011) Benzodiazepines revisited\u2014will we ever learn? Addiction 106(12):2086\u20132109","journal-title":"Addiction"},{"issue":"5","key":"2257_CR4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00002018-199005050-00003","volume":"5","author":"WH Kruse","year":"1990","unstructured":"Kruse WH (1990) Problems and pitfalls in the use of benzodiazepines in the elderly. Drug Saf 5(5):328\u2013344","journal-title":"Drug Saf"},{"key":"2257_CR5","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"SB Gage de","year":"2014","unstructured":"de Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, B\u00e9gaud B (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:g5205","journal-title":"BMJ"},{"key":"2257_CR6","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1136\/bmj.g5312","volume":"349","author":"K Yaffe","year":"2014","unstructured":"Yaffe K, Boustani M (2014) Benzodiazepines and risk of Alzheimer\u2019s disease. BMJ 349:5312","journal-title":"BMJ"},{"key":"2257_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4135\/9781452225555.n10","volume-title":"Treatment of late-life insomnia","author":"DJ Buysse","year":"2000","unstructured":"Buysse DJ, Reynolds CF (2000) Pharmacologic treatment. In: Lichstein KL, Morin CM (eds) Treatment of late-life insomnia. Sage Publications, Thousand Oaks-London-New Delhi, pp 231\u2013267"},{"issue":"4","key":"2257_CR8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1753-6405.2007.00091.x","volume":"31","author":"A Windle","year":"2007","unstructured":"Windle A, Elliot E, Duszynski K, Moore V (2007) Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health 31(4):379\u2013381","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"2257_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/0002512-200926020-00003","volume":"26","author":"AJ Smith","year":"2009","unstructured":"Smith AJ, Tett SE (2009) How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003-6. Drugs Aging 26(2):113\u2013122. doi: 10.2165\/0002512-200926020-00003","journal-title":"Drugs Aging"},{"issue":"5","key":"2257_CR10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.1367","volume":"16","author":"R Paulose-Ram","year":"2007","unstructured":"Paulose-Ram R, Safran MA, Jonas BS, Gu Q, Orwig D (2007) Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf 16(5):560\u2013570","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2257_CR11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13651500903447810","volume":"14","author":"J Donoghue","year":"2010","unstructured":"Donoghue J, Lader M (2010) Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract 14(2):78\u201387","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2257_CR12","first-page":"w13745","volume":"143","author":"F Hoffmann","year":"2013","unstructured":"Hoffmann F (2013) Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs. Swiss Med Wkly 143:w13745","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"2257_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imj.12315","volume":"44","author":"MM Islam","year":"2014","unstructured":"Islam MM, Conigrave KM, Day CA, Nguyen Y, Haber PS (2014) Twenty-year trends in benzodiazepine dispensing in the Australian population. Intern Med J 44(1):57\u201364. doi: 10.1111\/imj.12315","journal-title":"Intern Med J"},{"issue":"533","key":"2257_CR14","first-page":"964","volume":"56","author":"AN Siriwardena","year":"2006","unstructured":"Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M (2006) GPs\u2019 attitudes to benzodiazepine and \u2018Z-drug\u2019 prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 56(533):964\u2013967","journal-title":"Br J Gen Pract"},{"issue":"5","key":"2257_CR15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","volume":"38","author":"J Brett","year":"2015","unstructured":"Brett J, Murnion B (2015) Management of benzodiazepine misuse and dependence. Aust Prescr 38(5):152\u2013155","journal-title":"Aust Prescr"},{"issue":"2","key":"2257_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry 72(2):136\u2013142. doi: 10.1001\/jamapsychiatry.2014.1763","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"2257_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/pds.784","volume":"12","author":"R Hulten van","year":"2003","unstructured":"van Hulten R, Isacson D, Bakker A, Leufkens HG (2003) Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf 12(1):49\u201353. doi: 10.1002\/pds.784","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2257_CR18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/089198870001300309","volume":"13","author":"MD Llorente","year":"2000","unstructured":"Llorente MD, David D, Golden AG, Silverman MA (2000) Defining patterns of benzodiazepine use in older adults. J Geriatr Psychiatry Neurol 13(3):150\u2013160","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"2257_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S1516-44462006005000062","volume":"30","author":"JM Alvarenga","year":"2008","unstructured":"Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E (2008) Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambui Health and Aging Study (BHAS). Rev Bras Psiquiatr 30(1):7\u201311","journal-title":"Rev Bras Psiquiatr"},{"issue":"1","key":"2257_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1467-842X.2000.tb00715.x","volume":"24","author":"AF Jorm","year":"2000","unstructured":"Jorm AF, Grayson D, Creasey H, Waite L, Broe GA (2000) Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 24(1):7\u201310","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"2257_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2710.2009.01079.x","volume":"35","author":"JL Westbury","year":"2010","unstructured":"Westbury JL, Jackson S, Peterson GM (2010) Psycholeptic use in aged care homes in Tasmania, Australia. J Clin Pharm Ther 35(2):189\u2013193. doi: 10.1111\/j.1365-2710.2009.01079.x","journal-title":"J Clin Pharm Ther"},{"key":"2257_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gps.930070205","volume":"7","author":"C Salzman","year":"1992","unstructured":"Salzman C, Fisher J, Nobel K, Glassman R, Wolfson A, Kelley M (1992) Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 7:89\u201393","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"2257_CR23","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80(6):1254\u20131268","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2257_CR24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ijpp.12093","volume":"22","author":"DP Alldred","year":"2014","unstructured":"Alldred DP (2014) Deprescribing: a brave new word? Int J Pharm Pract 22(1):2\u20133","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"2257_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.18773\/austprescr.2011.095","volume":"34","author":"DG Le Couteur","year":"2011","unstructured":"Le Couteur DG, Banks E, Gnjidic D, McLachlan A (2011) Deprescribing. Aust Prescr 34(6):182\u2013185","journal-title":"Aust Prescr"},{"issue":"7","key":"2257_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5694\/mja13.00200","volume":"201","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD (2014) The benefits and harms of deprescribing. Med J Aust 201(7):386\u2013389. doi: 10.5694\/mja13.00200","journal-title":"Med J Aust"},{"key":"2257_CR27","doi-asserted-by":"crossref","first-page":"g7013","DOI":"10.1136\/bmj.g7013","volume":"349","author":"D Gnjidic","year":"2014","unstructured":"Gnjidic D, Le Couteur DG, Hilmer SN (2014) Discontinuing drug treatments. BMJ 349:g7013","journal-title":"BMJ"},{"key":"2257_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","volume":"16","author":"AS Pollmann","year":"2015","unstructured":"Pollmann AS, Murphy AL, Bergman JC, Gardner DM (2015) Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol 16:19. doi: 10.1186\/s40360-015-0019-8","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"2257_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/bjp.bp.113.126003","volume":"204","author":"RL Gould","year":"2014","unstructured":"Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ (2014) Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry 204(2):98\u2013107. doi: 10.1192\/bjp.bp.113.126003","journal-title":"Br J Psychiatry"},{"issue":"5","key":"2257_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336\u2013341. doi: 10.1016\/j.ijsu.2010.02.007","journal-title":"Int J Surg"},{"key":"2257_CR31","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. doi: 10.1136\/bmj.d5928","journal-title":"BMJ"},{"issue":"10","key":"2257_CR32","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00228-014-1725-7","volume":"70","author":"J Bourgeois","year":"2014","unstructured":"Bourgeois J, Elseviers MM, Van Bortel L, Petrovic M, Stichele RHV (2014) Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol 70(10):1251\u20131260","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2257_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03324897","volume":"21","author":"C Garzon","year":"2009","unstructured":"Garzon C, Guerrero JM, Aramburu O, Guzman T (2009) Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study. Aging Clin Exp Res 21(1):38\u201342","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"2257_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<754::AID-GPS15>3.0.CO;2-E","volume":"14","author":"M Petrovic","year":"1999","unstructured":"Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M (1999) A program for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry 14(9):754\u2013760. doi: 10.1002\/(SICI)1099-1166(199909)14:9<754::AID-GPS15>3.0.CO;2-E","journal-title":"Int J Geriatr Psychiatry"},{"issue":"11","key":"2257_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-001-0387-4","volume":"57","author":"M Petrovic","year":"2002","unstructured":"Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M (2002) Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial. Eur J Clin Pharmacol 57(11):759\u2013764. doi: 10.1007\/s00228-001-0387-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2257_CR36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ageing\/afp255","volume":"39","author":"M Salonoja","year":"2010","unstructured":"Salonoja M, Salminen M, Aarnio P, Vahlberg T, Kivela SL (2010) One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing 39(3):313\u2013319","journal-title":"Age Ageing"},{"key":"2257_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.949","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S (2014) Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. doi: 10.1001\/jamainternmed.2014.949","journal-title":"JAMA Intern Med"},{"issue":"7","key":"2257_CR38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1017\/S0033291703008213","volume":"33","author":"H Curran","year":"2003","unstructured":"Curran H, Collins R, Fletcher S, Kee S, Woods B, Iliffe S (2003) Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med 33(7):1223\u20131237","journal-title":"Psychol Med"},{"key":"2257_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13063-015-0791-1","volume":"16","author":"P Martin","year":"2015","unstructured":"Martin P, Tamblyn R, Ahmed S, Benedetti A, Tannenbaum C (2015) A consumer-targeted, pharmacist-led, educational intervention to reduce inappropriate medication use in community older adults (D-PRESCRIBE trial): study protocol for a cluster randomized controlled trial. Trials 16:266. doi: 10.1186\/s13063-015-0791-1","journal-title":"Trials"},{"issue":"1","key":"2257_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/S1041610209991128","volume":"22","author":"J Westbury","year":"2010","unstructured":"Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatrics 22(1):26\u201336. doi: 10.1017\/S1041610209991128","journal-title":"Int Psychogeriatrics"},{"key":"2257_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/1756-0500-5-684","volume":"5","author":"C Lopez-Peig","year":"2012","unstructured":"Lopez-Peig C, Mundet X, Casabella B, del Val JL, Lacasta D, Diogene E (2012) Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain. BMC Res Notes 5:684. doi: 10.1186\/1756-0500-5-684","journal-title":"BMC Res Notes"},{"issue":"5","key":"2257_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/jcp.0000000000000383","volume":"35","author":"C Salzman","year":"2015","unstructured":"Salzman C, Shader RI (2015) Not again: benzodiazepines once more under attack. J Clin Psychopharmacol 35(5):493\u2013495. doi: 10.1097\/jcp.0000000000000383","journal-title":"J Clin Psychopharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2257-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T22:24:02Z","timestamp":1658960642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,30]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2257-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,30]]}}}